Is there a rationale for the continuous infusion of cefepime? A multidisciplinary approach
| Autor: | G. Potel, J.-P. Bru, I. Lavrard, D. Chiche, I. Dujardin, F. Goldstein, E. Bernard, R. Garraffo, D. Breilh |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Microbiology (medical)
Cefotaxime Cystic Fibrosis Continuous infusion medicine.drug_class Cefepime Cephalosporin Antibiotics Ceftazidime Microbial Sensitivity Tests Pharmacology Drug Administration Schedule medicine Humans Infusions Intravenous Antibacterial agent Clinical Trials as Topic business.industry dosage regimen β-lactamas Bacterial Infections General Medicine continuous infusion Cephalosporins Treatment Outcome Infectious Diseases Ceftriaxone business medicine.drug |
| Zdroj: | Clinical Microbiology and Infection. 9:339-348 |
| ISSN: | 1198-743X |
| Popis: | This review is the fruit of multidisciplinary discussions concerning the continuous administration of beta-lactams, with a special focus on cefepime. Pooling of the analyses and viewpoints of all members of the group, based on a review of the literature on this subject, has made it possible to test the hypothesis concerning the applicability of this method of administering cefepime. Cefepime is a cephalosporin for injection which exhibits a broader spectrum of activity than that of older, third-generation cephalosporins for injection (cefotaxime, ceftriaxone, ceftazidime). The specific activity of cefepime is based on its more rapid penetration (probably due to its zwitterionic structure, this molecule being both positively and negatively charged) through the outer membrane of Gram-negative bacteria, its greater affinity for penicillin-binding proteins, its weak affinity for beta-lactamases, and its stability versus certain beta-lactamases, particularly derepressed cephalosporinases. The stability of cefepime in various solutions intended for parenteral administration has been studied, and the results obtained demonstrated the good compatibility of cefepime with these different solutions. These results thus permit the administration of cefepime in a continuous infusion over a 24-h period, using two consecutive syringes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|